Maresin 1 mitigatesLPS‐induced acute lung injury in mice

Authors:

Abstract
Background and Purpose: Acute lung injury (ALI) is a severe illness with a high rate of mortality.Maresin 1 (MaR1) was recently reported to regulate inflammatory responses. We used aLPS‐inducedALImodel to determine whetherMaR1can mitigate lung injury.Experimental Approach: MaleBALB/c mice were injected, intratracheally, with eitherLPS(3 mg·kg−1) or normal saline (1.5 mL·kg−1). After this, normal saline, a low dose ofMaR1(0.1 ng per mouse) or a high dose ofMaR1(1 ng per mouse) was given i.v. Lung injury was evaluated by detecting arterial blood gas, pathohistological examination, pulmonary oedema, inflammatory cell infiltration, inflammatory cytokines in the bronchoalveolar lavage fluid and neutrophil–platelet interactions.Key Results: The high dose ofMaR1significantly inhibitedLPS‐inducedALIby restoring oxygenation, attenuating pulmonary oedema and mitigating pathohistological changes. A combination ofelisaand immunohistochemistry showed that high‐doseMaR1attenuatedLPS‐induced increases in pro‐inflammatory cytokines (TNF‐α,IL‐1β andIL‐6), chemokines [keratinocyte chemokine, monocyte chemoattractant protein‐5, macrophage inflammatory protein (MIP)‐1α andMIP‐1γ], pulmonary myeloperoxidase activity and neutrophil infiltration in the lung tissues. Consistent with these observations, flow cytometry and Western blotting indicated thatMaR1down‐regulatedLPS‐induced neutrophil adhesions and suppressed the expression of intercellular adhesion molecule (ICAM)‐1,P‐selection andCD24.Conclusions and Implications: High‐doseMaR1mitigatedLPS‐induced lung injury in mice by inhibiting neutrophil adhesions and decreasing the levels of pro‐inflammatory cytokines.
Funding Information
  • National Natural Science Foundation of China (30930089, 81372036)
  • Key Clinical Project of Ministry of Health of China (2010-47)

This publication has 53 references indexed in Scilit: